Back to results
US 2016/0095908 A1Published application
Botulinum Toxin for Primary Disorders of Mood and Affect using Neurotransmitter CNS imaging Studies
AssigneeBotulinum Toxin Research Associates, Inc.
InventorsGary E. Borodic, Martin Acquadro
Life of this patent
Estimating the term…
Abstract
The invention provides methods for treating primary disorders of mood and affect, including depressive disorders, anxiety, and sleep disorders and CNS disorders comprising the administration of a neurotoxin.
Claims20
A method of treatment of a central nervous system disorder defined as an having an abnormality in at least one brain neurotransmitter in at least one or more regions of the brain comprising a method of:
- a. injection of botulinum toxin into the extra cranial region of the head or neck
- b. such that the extra cranial region of the head and neck is in close proximity with one region of the brain with abnormal neurotransmitter activity determination using a PET scan, functional Magnetic resonance imaging or brain scan
- c. wherein the botulinum toxin blocks neurotransmission involving at least one neurotransmitter.
The method of 1, wherein the disorder is related to seizures.
Dependencies are inferred from the claim text.